Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1 billion, the Wall Street Journal has reported, citing people familiar with the matter. Shares of Ventyx closed up 5.2% following the report, which said the deal could be announced imminently. A potential buyout of Ventyx will add drugs for inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis to Lilly’s portfolio, along with treatments for conditions like Parkinson’s.
Read the full article: Lilly in Talks to Buy Ventyx Biosciences for More Than $1B, WSJ Reports //
Source: https://finance.yahoo.com/news/lilly-talks-buy-ventyx-biosciences-204823398.html